Patent Assignment
Reel/Frame 055133/0214
Release of Security Interest
Recorded: 2021-01-27
Pages: 6
Assignor
HORIZON TECHNOLOGY FINANCE CORPORATION, AS COLLATERAL AGENT
Executed: 2021-01-21
Assignee
VTV THERAPEUTICS LLC
3980 PREMIER DRIVE, SUITE 310, HIGH POINT, NORTH CAROLINA, 27265
Covered Properties
(67)
Azole Derivatives and Fused Bicyclic Azole Derivatives as Therapeutic Agents
Aryl Carbonyl Derivatives as Therapeutic Agents
Rage Fusion Proteins
Azole Derivatives and Fused Bicyclic Azole Derivatives as Therapeutic Agents
Rage Fusion Proteins
Substituted Imidazole Derivatives, Compositions, and Methods of Use as Ptpase Inhibitors
Rage Fusion Proteins, Formulations, and Methods of Use Thereof
Azole Derivatives and Fused Bicyclic Azole Derivatives as Therapeutic Agents
Aryl Carbonyl Derivatives as Therapeutic Agents
Aryl Carbonyl Derivatives as Therapeutic Agents
Dicycloalkyl Urea Glucokinase Activators
Crystalline Forms of [3-(4- {2-Butyl- 1 -[4-(4-Chloro-Phenoxy)-Phenyl]-1H-Imidazol-4-Yl} -Phenoxy)-Propyl]-Diethyl-Amine
3-(L,3-Benzodioxol-5-Yl)-6-(4-Cyclopropylpiperazin-L-Yl)-Pyridazine, Its Salts and Solvates and Its Use as Histamine H3 Receptor Antagonist
Oxadiazoanthracene Compounds for the Treatment of Diabetes
Urea Glucokinase Activators
N-Adamantyl Benzamides as Inhibitors of 11-Beta-Hydroxysteroid Dehydrogenase
Tricyclic Compounds as Modulators of Tnf-Alpha Synthesis
Substituted Imidazole Derivatives, Compositions, and Methods of Use as Ptpase Inhibitors
Oxadiazoanthracene Compounds for the Treatment of Diabetes
Substituted Azoanthracene Derivatives, Pharmaceutical Compositions, and Methods of Use Thereof
Oxadiazoanthracene Compounds for the Treatment of Diabetes
Oxadiazoanthracene Compounds for the Treatment of Diabetes
Substituted Imidazole Derivatives And Methods Of Use Thereof
Ligands For The GLP-1 Receptor And Methods For Discovery Thereof
Urea Glucokinase Activators
Crystalline Forms of [3-(4- {2-Butyl- 1 -[4-(4-Chloro-Phenoxy)-Phenyl]-1H-Imidazol-4-Yl} -Phenoxy)-Propyl]-Diethyl-Amine
Rage Fusion Proteins and Methods of Use
Phenyl-Heteroaryl Derivatives and Methods of Use Thereof
Substituted Fused Imidazole Derivatives, Pharmaceutical Compositions, and Methods of Use Thereof
Tricyclic Compounds as Modulators of Tnf-Alpha Synthesis and as PDE4 Inhibitors
Use of Metformin in Combination with a Glucokinase Activator and Compositions Comprising Metformin and a Glucokinase Activator
Adamantyl Benzamide Derivatives
Control of RAGE Fusion Protein Glycosylation and RAGE Fusion Protein Compositions
Tricyclic Compounds as Modulators of Tnf-Alpha Synthesis and as PDE4 Inhibitors
Urea Glucokinase Activators
Substituted Azoanthracene Derivatives, Pharmaceutical Compositions, and Methods of Use Thereof
N-Adamantyl Benzamides as Inhibitors of 11-Beta-Hydroxysteroid Dehydrogenase
Phenyl-Heteroaryl Derivatives and Methods of Use Thereof
Compounds That Modulate Oxidative Stress
Phenylglyoxylic Acid Derivatives and Their Preparation and Use
Oxadiazoanthracene Compounds for the Treatment of Diabetes
Substituted Imidazole Derivatives and Methods of Use Thereof
Treatment of Mild and Moderate Alzheimer's Disease
Glucokinase Activator Compositions for the Treatment of Diabetes
Oxadiazoanthracene Compounds for the Treatment of Diabetes
Substituted Fused Imidazole Derivatives, Pharmaceutical Compositions, and Methods of Use Thereof
Phenyl-Heteroaryl Derivatives and Methods of Use Thereof
N-Adamantyl Benzamides as Inhibitors of 11-Beta-Hydroxysteroid Dehydrogenase
Tricyclic Compounds as Modulators of Tnf-Alpha Synthesis and as PDE4 Inhibitors
Tris(hydroxymethyl)Aminomethane Salts of a Small-Molecule GLP1R Agonist and Pharmaceutical Compositions and Uses Thereof
Oxadiazoanthracene Compounds for the Treatment of Diabetes
Substituted Azoanthracene Derivatives and Intermediates for Preparation Thereof
Combinations of a GLP1R Agonist and Metformin and Use Thereof for the Treatment of Type 2 Diabetes and Other Disorders
Application:
14/799,222 →
Publication:
US 2015/0313908
Solid Compositions Comprising a Glucokinase Activator and Methods of Making and Using the Same
Application:
14/840,657 →
Publication:
US 2016/0015816
Stable Glucokinase Activator Compositions
Application:
14/840,682 →
Publication:
US 2016/0015638
Tricyclic Compounds as Modulators of Tnf-Alpha Synthesis and as PDE4 Inhibitors
Use of Metformin in Combination with a Glucokinase Activator and Compositions Comprising Metformin and a Glucokinase Activator
Tricyclic Compounds as Modulators of Tnf-Alpha Synthesis and as PDE4 Inhibitors
Compounds That Modulate Oxidative Stress
Substituted Imidazole Derivatives and Methods of Use Thereof
Application:
15/438,111 →
Publication:
US 2017/0157093
Bach1 Inhibitors in Combination with Nrf2 Activators and Pharmaceutical Compositions Thereof
Tricyclic Compounds as Modulators of Tnf-Alpha Synthesis and as PDE4 Inhibitors
Treatment of Mild and Moderate Alzheimer's Disease
Application:
15/631,203 →
Publication:
US 2017/0326113
Use of Metformin in Combination with a Glucokinase Activator and Compositions Comprising Metformin and a Glucokinase Activator
Tricyclic Compounds as Modulators of Tnf-Alpha Synthesis and as PDE4 Inhibitors
Crystalline Forms of [3-(4- {2-Butyl-1-[4-(4-Chloro-Phenoxy)-Phenyl]-1H-Imidazol-4-Yl} -Phenoxy)-Propyl]-Diethyl-Amine
Application:
62/649,161 →
Pharmaceutically Acceptable Salts of [3-(4- {2-Butyl-1-[4-(4-Chloro-Phenoxy)-Phenyl]-1H-Imidazol-4-Yl} -Phenoxy)-Propyl]-Diethyl-Amine
Application:
62/649,173 →
Related Assignments
(21)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Dec 11, 2009
From: MJALLI, ADNAN M.M.; POLISETTI, DHARMA RAO; YOKUM, THOMAS SCOTT; SANTHOSH, KALPATHY
To: TRANSTECH PHARMA, INC.
Reel/Frame 023638/0840 →
Assignment of Assignor's Interest
Oct 11, 2012
From: NOVO NORDISK A/S
To: TRANSTECH PHARMA, INC.
Reel/Frame 029112/0134 →
Confirmation of Termination of Exclusive Patent License
Jan 15, 2013
From: PFIZER, INC.
To: TRANSTECH PHARMA, INC.
Reel/Frame 029631/0111 →
Security Agreement
Aug 9, 2013
From: TRANSTECH PHARMA, INC.
To: M&F TTP HOLDINGS LLC C/O MACANDREWS & FORBES HOLDINGS INC.
Reel/Frame 030982/0803 →
Security Agreement
Aug 9, 2013
From: HIGH POINT PHARMACEUTICALS, LLC
To: M&F TTP HOLDINGS LLC C/O MACANDREWS & FORBES HOLDINGS INC.
Reel/Frame 030982/0793 →
Assignment of Assignor's Interest
Nov 22, 2013
From: TRANSTECH PHARMA, INC.
To: TRANSTECH PHARMA, LLC
Reel/Frame 031654/0878 →
Notice of Release of Security Interest in Patents for Reel/Frame 030982/0803
Apr 7, 2014
From: M&F TTP HOLDINGS LLC
To: TRANSTECH PHARMA, LLC
Reel/Frame 032621/0860 →
Notice of Release of Security Interest in Patents for Reel/Frame 030982/0793
Apr 7, 2014
From: M&F TTP HOLDINGS LLC
To: HIGH POINT PHARMACEUTICALS, LLC
Reel/Frame 032621/0867 →
Security Interest
Feb 26, 2015
From: TRANSTECH PHARMA, LLC
To: M&F TTP HOLDINGS LLC, AS COLLATERAL AGENT
Reel/Frame 035103/0356 →
Security Interest
Feb 26, 2015
From: HIGH POINT PHARMACEUTICALS, LLC
To: M&F TTP HOLDINGS LLC, AS COLLATERAL AGENT
Reel/Frame 035103/0029 →
Change of Name
Jun 25, 2015
From: TRANSTECH PHARMA, LLC
To: VTV THERAPEUTICS LLC
Reel/Frame 036026/0219 →
Change of Name
Jul 30, 2015
From: VTV THERAPEUTICS LLC
To: VTVX HOLDINGS I LLC
Reel/Frame 036236/0165 →
Change of Name
Jul 30, 2015
From: HIGH POINT PHARMACEUTICALS, LLC
To: VTVX HOLDINGS II LLC
Reel/Frame 036236/0159 →
Assignment of Assignor's Interest
Jul 31, 2015
From: VTVX HOLDINGS II LLC
To: VTV THERAPEUTICS LLC
Reel/Frame 036242/0362 →
Assignment of Assignor's Interest
Jul 31, 2015
From: VTVX HOLDINGS I LLC
To: VTV THERAPEUTICS LLC
Reel/Frame 036242/0354 →
Release of Security Interest
Aug 3, 2015
From: M&F TTP HOLDINGS LLC, AS COLLATERAL AGENT
To: VTVX HOLDINGS I LLC
Reel/Frame 036254/0792 →
Release of Security Interest
Aug 3, 2015
From: M&F TTP HOLDINGS LLC, AS COLLATERAL AGENT
To: VTVX HOLDINGS II LLC
Reel/Frame 036254/0780 →
Corrective Assignment to Correct the Receiving Party Data Previously Recorded at Reel: 036254 Frame: 0780. Assignor(S) Hereby Confirms the Assignment.
Sep 24, 2015
From: M&F TTP HOLDINGS LLC, AS COLLATERAL AGENT
To: VTVX HOLDINGS I LLC
Reel/Frame 036675/0407 →
Corrective Assignment to Correct the Receiving Party Data Previously Recorded at Reel: 036254 Frame: 0792. Assignor(S) Hereby Confirms the Assignment.
Sep 24, 2015
From: M&F TTP HOLDINGS LLC, AS COLLATERAL AGENT
To: VTVX HOLDINGS II LLC
Reel/Frame 036675/0399 →
Assignment of Assignor's Interest
Sep 6, 2017
From: NOVO NORDISK A/S
To: VTV THERAPEUTICS LLC
Reel/Frame 043496/0345 →
Security Interest
Apr 18, 2018
From: VTV THERAPEUTICS LLC
To: HORIZON TECHNOLOGY FINANCE CORPORATION, AS COLLATERAL AGENT
Reel/Frame 045969/0774 →